Mesirow Financial Investment Management, Inc. Neogenomics Inc Transaction History

Mesirow Financial Investment Management, Inc.

$4.79 Billion
Q4 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 11, 2018	SELL	$7.99 - $14.05 $354,636 - $623,609	-44,385 Closed	0 $0
Q1 2018 Apr 17, 2018	BUY	$7.23 - $8.76 $90,743 - $109,946	12,551 Added 39.43%	44,385 $362,000
Q4 2017 Jan 16, 2018	BUY	$8.02 - $11.18 $4,539 - $6,327	566 Added 1.81%	31,834 $282,000
Q3 2017 Oct 12, 2017	SELL	$9.11 - $11.26 $376,725 - $465,634	-41,353 Reduced 56.94%	31,268 $348,000
Q2 2017 Aug 17, 2017	BUY	N/A	72,621	72,621 $651,000

Others Institutions Holding NEO

# of Institutions

294

Shares Held

124M

Call Options Held

698K

Put Options Held

116K

Black Rock Inc. New York, NY

19.7M
Shares

$265 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

14M
Shares

$189 Million
0.0% of portfolio
Brown Advisory Inc

6.89M
Shares

$92.7 Million
0.13% of portfolio
Janus Henderson Group PLC London, X0

6.6M
Shares

$88.8 Million
0.05% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

6.54M
Shares

$88 Million
0.06% of portfolio

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.69B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.

Account